CLAYTON, Mo., Jan. 8, 2026 /PRNewswire/ -- Olin Corporation (NYSE: OLN), today announced an updated outlook for the fourth quarter 2025. Olin now expects fourth quarter 2025 adjusted EBITDA to be approximately $67 million compared to the previous outlook of $110 to $130 million. Most of the earnings shortfall occurred within the Chlor Alkali Products and Vinyls business, reflecting an extended planned maintenance turnaround and unplanned downtime at our Freeport, Texas operations, as well as lower-than-exp ...

Core Insights - Olin Corporation's shares have faced significant challenges, with a 48.69% decline over the past year, attributed to factors such as subsidized imports from Asia and Europe [4][9] - Teresa M. Vermillion, the VP & Treasurer, sold 4,500 shares through an option exercise, resulting in a 20.74% reduction in her direct ownership [7][9] - The company is focusing on its core chemical and ammunition segments, with a recent strategic partnership with Braskem aimed at enhancing growth in its vinyls business [10][11] Company Overview - Olin Corporation operates in the chemicals and ammunition sectors, generating revenue of $6.8 billion and a net income of $53.80 million [4][5] - The company has a dividend yield of 3.9% and has seen a 1-year price change of -48.69% [4] Transaction Details - The transaction involved the sale of shares at a weighted average price of approximately $20.86, with a total transaction value of around $93,850.20 [2][7] - Post-transaction, Vermillion holds 17,199 shares, valued at approximately $353,783.43 [2][7] Market Context - The company's stock performance has been negatively impacted by subdued global demand in the epoxy market and lower-than-expected ammunition sales [10] - The recent insider transaction is viewed as administrative rather than indicative of the company's future performance [7][9]

Core Insights - Warren Buffett will step down as CEO of Berkshire Hathaway on January 1, 2026, while remaining as chairman, with Greg Abel set to succeed him [1] - Buffett executed a $9.7 billion deal to acquire OxyChem from Occidental Petroleum shortly before the leadership transition [1][2] Company Background - Berkshire Hathaway has a long-standing relationship with Occidental Petroleum, having provided a $10 billion loan in 2019 for its acquisition of Anadarko Petroleum [4] - Berkshire has been increasing its stake in Occidental, currently owning 26.9% of the company, valued at approximately $11.7 billion [5][6] Acquisition Details - The $9.7 billion purchase price for OxyChem is significant compared to Occidental's market cap of $43.6 billion [6] - OxyChem is involved in producing chemicals for various applications, including chlorine and polyvinyl chloride, and plays a role in Occidental's carbon capture initiatives [7] Strategic Implications - The acquisition aligns with Berkshire Hathaway's investment strategy, focusing on underappreciated businesses rather than high-growth stocks [8] - The sale of OxyChem is not expected to hinder Occidental's low-carbon goals but indicates a shift towards projects that generate immediate free cash flow [9]

Core Insights - Berkshire Hathaway is acquiring Occidental Petroleum's chemical unit, OxyChem, for $9.7 billion in cash, marking its largest deal in three years just before Warren Buffett's retirement as CEO [1][9] - Berkshire has significantly increased its stake in Occidental Petroleum, reaching 32.7% by August 2025, making it the sixth-largest holding in its portfolio [2] - The acquisition focuses solely on OxyChem, a key manufacturer of chemicals, rather than full control of Occidental [3] Financial Performance - OxyChem generated $1.1 billion in operating income for the fiscal year ending December 31, 2024, contributing approximately 16% to Occidental's total income [6] - Occidental's capital expenditures for OxyChem are projected to rise by $200 million to $900 million in 2025, indicating a commitment to growth in this segment [6] Debt and Financial Strategy - The sale of OxyChem will provide Occidental with $6.5 billion to repay debt, enhancing its balance sheet and allowing for potential share repurchases and dividend growth [7] - Occidental's debt concerns have been exacerbated by its $12 billion acquisition of CrownRock in 2024, primarily financed through borrowing [7] Market Implications - The divestiture of OxyChem will position Occidental as a more focused oil and gas company, increasing its vulnerability to fluctuations in commodity prices [8]

Group 1 - Berkshire Hathaway is acquiring Occidental Petroleum's chemical division, OxyChem, for $9.7 billion, marking a significant transaction for the company [1] - The acquisition utilizes less than 3% of Berkshire's cash reserves, which exceed $344 billion, and is not expected to significantly impact the conglomerate's financial performance [5][4] - OxyChem produces various chemicals, including chlorine for water treatment and vinyl chloride for plastics, complementing Berkshire's existing portfolio, particularly Lubrizol [6] Group 2 - Warren Buffett's involvement in the deal is implied, despite his absence in the official announcement, indicating a potential transition of leadership to Vice Chair Greg Abel [2][3] - Analysts are observing how Abel's leadership style and deal-making approach may differ from Buffett's as he prepares to take over as CEO [7][8] - The market reaction to the acquisition was lukewarm, with Berkshire's shares slightly declining and Occidental's shares dropping over 7% following the announcement [5]

Core Insights - Berkshire Hathaway has agreed to acquire Occidental Petroleum's OxyChem segment for $9.7 billion, with the transaction expected to close in Q4 2025 [1][5]. Group 1: Acquisition Details - OxyChem produces standardized chemicals used in various applications, including water treatment, pharmaceuticals, and construction [2]. - The chemicals manufactured by OxyChem include chlorine, caustic soda, polyvinyl chloride, and ethylene [2]. - Occidental's other subsidiary will retain OxyChem's legacy environmental liabilities, while Glenn Springs Holdings will manage existing remedial projects [3]. Group 2: Strategic Implications - The acquisition enhances Occidental Petroleum's financial position, allowing the company to concentrate on its core oil and gas business and pursue further development and acquisitions [5]. - OxyChem has been recognized as a well-managed business with skilled employees, and there is confidence in its continued success under Berkshire Hathaway's ownership [6]. Group 3: Operational Footprint - OxyChem operates manufacturing plants at 21 domestic sites across various states in the U.S. and at two international locations in Canada and Chile [6].

Financial Data and Key Metrics Changes - For Q2 2025, the company reported EBITDA of $350 million on net sales of $3 billion, with a net loss of $12 million or $0.09 per share [8][14] - Compared to Q2 2024, net income decreased by $325 million due to higher North American feedstock and energy costs, and lower average sales prices across segments [14][19] - The company achieved over $75 million in cost reductions towards a full-year target of $150 million to $175 million [13][21] Business Line Data and Key Metrics Changes - The Housing and Infrastructure Products (HIP) segment delivered EBITDA of $275 million on sales of $1.2 billion, with a 24% EBITDA margin, driven by a 14% increase in sales volumes [8][17] - The Performance and Essential Materials (PEM) segment saw sales of $1.8 billion, down $57 million from Q1 2025, with EBITDA of $52 million, significantly impacted by planned turnarounds and unplanned outages [19][18] - The HIP segment's sales volume growth was supported by increasing demand for municipal water applications, while the Building Products business faced a slowdown due to reduced residential construction activity [10][17] Market Data and Key Metrics Changes - The company noted a significant underspending on water infrastructure in the U.S., which is expected to support pipe and fitting sales for years to come [10] - The global manufacturing activity has been soft, leading to a cumulative impact on PEM sales volumes and pricing [11][25] - The company anticipates stable demand for PEM materials, with improved production rates expected to lead to increased sales volumes compared to Q2 2025 [25] Company Strategy and Development Direction - The company is implementing a three-pronged profitability improvement strategy for PEM, focusing on improving plant reliability, reducing costs, and optimizing the manufacturing footprint [12][25] - The HIP segment strategy emphasizes providing products that address affordability and adapting offerings as market conditions evolve [17][22] - The company remains positive about the long-term growth outlook for HIP, expecting a 5% to 7% compound annual growth rate driven by market recovery and strategic acquisitions [24][22] Management Comments on Operating Environment and Future Outlook - Management acknowledged the challenging operating environment due to elevated interest rates and soft macroeconomic conditions but highlighted the resilience of the HIP segment [8][22] - The company expects the impact of production disruptions to lessen in Q3 2025, with improved sales volumes anticipated [21][25] - Management emphasized the foundational strengths of the company, including a diversified portfolio and a strong balance sheet, to create long-term value for shareholders [26] Other Important Information - The company announced the planned closure of its epoxy site in Pernice, The Netherlands, which is expected to lead to profitability in 2026 [19][20] - As of June 30, 2025, the company had cash and investments of $2.3 billion and total debt of $4.7 billion [20] Q&A Session Summary Question: Guidance on HIP margins and pricing pressures - Management indicated that margins are expected to remain in the 20% to 22% range despite lower sales guidance, reflecting the realities of the residential building market [30][32] Question: Impact of tariffs on exports - Management noted that current tariffs have not significantly impacted exports to Brazil, as customers can access duty drawbacks [34] Question: Performance in HIP and pricing pressures - Management highlighted the strength in the water business and the ability to adapt to market conditions, maintaining stable margins despite pricing pressures [38][39] Question: Planned turnarounds and cost savings - The majority of the $110 million impact from outages was due to planned turnarounds, with no major turnarounds expected in the second half of 2025 [44][45] Question: M&A opportunities in PEM - Management stated that they are open to M&A opportunities across both HIP and PEM segments, driven by valuation opportunities [50] Question: Plant reliability improvements - Management confirmed that improvements in plant reliability have been observed since late April, with expectations for continued progress in Q3 [66][67] Question: Chlor alkali supply outlook - Management expressed confidence in market stability and anticipated demand growth by the end of the decade [112]

Financial Performance - Hawkins' 2025 revenue reached $9744 million[10] - The company's 5-year EPS CAGR is 25%[10] - Net income in fiscal year 2025 was $843 million, with a 24% CAGR[67] - Adjusted EBITDA in fiscal year 2025 was $1675 million, with a 21% CAGR[69] - Diluted EPS in fiscal year 2025 was $403, with a 25% CAGR[74] - Q1 Fiscal Year 2026 revenue reached a record $2933 million, a 15% increase year-over-year[81] - Q1 Fiscal Year 2026 Adjusted EBITDA reached a record $574 million, a 13% increase year-over-year[81] Business Segments - Water Treatment accounted for 46% of revenue, totaling $4465 million[15] - Food & Health Sciences accounted for 33% of revenue, totaling $3225 million[15] - Industrial Solutions accounted for 21% of revenue, totaling $2054 million[15] Capital Allocation - The company has consistently returned capital to shareholders through dividends and share repurchases[32] - Hawkins has a track record of 40 consecutive years of cash dividends[33]

Core Insights - Olin reported Q2 2025 revenue of $1,758.3 million, exceeding analyst expectations by 6.0% but posted a GAAP loss per share of ($0.01), missing the consensus forecast of a $0.01 profit [1][2] - Adjusted EBITDA fell 36.6% to $176.1 million compared to the same period last year, indicating profitability pressures from rising input costs and maintenance expenses [1][2] Financial Performance - Revenue increased by 7.0% year-over-year from $1,644.0 million in Q2 2024 to $1,758.3 million in Q2 2025 [2] - Chlor Alkali Products and Vinyls revenue rose 6.4% to $979.5 million, while Epoxy revenue grew 4.2% to $331.2 million, and Winchester revenue increased 10.2% to $447.6 million [2][5][6][7] - GAAP EPS decreased by 101.6% from $0.62 in Q2 2024 to ($0.01) in Q2 2025, while adjusted EBITDA dropped from $278.1 million to $176.1 million [2][5] Business Segments Overview - The Chlor Alkali segment faced a 34.6% decline in earnings due to lower prices and higher maintenance costs, despite increased volumes [5] - The Epoxy segment experienced a deeper operating loss driven by rising costs and global oversupply, with flat profit margins year-over-year [6] - Winchester's sales rose due to military shipments, but earnings declined approximately 64% due to weak commercial sales and rising raw material costs [7] Strategic Focus - Olin is concentrating on maximizing value in its Chlor Alkali business, enhancing integration in Epoxy, and expanding the Winchester military channel [4] - Key success factors include maintaining low production costs, securing long-term military contracts, and effective capital allocation [4] Outlook - Management expects Q3 2025 adjusted EBITDA to range from $170 million to $210 million, indicating continued challenges [12] - Capital expenditures for 2025 have been trimmed by $25 million as part of cost control measures, with no upward revision to full-year earnings expectations [12]

Financial Data and Key Metrics Changes - The company is increasing its cost reduction target to $50 million to $70 million for full year 2025 related to productivity and structural cost improvements [8] - First quarter operating cash flow was negatively impacted by normal seasonal working capital growth, but by year-end, working capital is expected to be a source of cash flow for 2025 [29] - The company expects second quarter adjusted EBITDA to be in the range of $170 million to $210 million, including a $40 million sequential chemicals turnaround expense headwind [34] Business Line Data and Key Metrics Changes - Chlor Alkali Products and Vinyls business exceeded expectations due to planned and unplanned industry outages, leading to higher sales and lower turnaround costs [9][26] - The Winchester division saw growth in domestic and international military ammunition volume, while commercial sales remained weak due to destocking by retailers [10][20] - The Epoxy business experienced improved sales sequentially, but margin benefits were offset by higher costs [16][17] Market Data and Key Metrics Changes - Stable ECU values continued with positive pricing trends into the second quarter, particularly for caustic soda [10][32] - The commercial ammunition market is currently challenged, with mid-single-digit pullbacks in sporting goods and hunting sales [21] - The company does not expect significant direct impact from current tariffs on CAPB, as export sales are generally sold to low-tariff countries [15] Company Strategy and Development Direction - The company is focused on a value-first commercial approach and has made solid progress in implementing its Winchester growth strategy [11][24] - The acquisition of Ammo Inc. manufacturing assets is expected to be immediately accretive and supports growth for Winchester [24] - The company is exploring long-term strategic opportunities in the PVC market, including potential joint ventures [15][83] Management's Comments on Operating Environment and Future Outlook - Management noted that economic uncertainty continues to dominate the global macro environment, but the company is focused on managing controllable factors [7] - The outlook for the second quarter indicates cautious optimism, with expectations of stable demand and pricing for caustic soda [32][66] - The company remains committed to maintaining its investment-grade balance sheet and disciplined capital allocation approach [30] Other Important Information - The company successfully refinanced its nearest debt tranche, extending maturities to 2029, which positions it well to weather economic uncertainty [10] - A new board member, retired U.S. Army General Edward M. Daley, was elected to provide strategic guidance [35] Q&A Session Summary Question: Update on volume and price outlook for chlorovinyl - Management noted continued weakness in EDC pricing but expects positive pricing trends for caustic soda in Q2 [38][39] Question: Cash positive status of PVC arrangement - Management confirmed that the current PVC arrangement is cash positive and plans to ramp up tolling volumes [41][42] Question: Operating rates in Q1 - Management indicated that operating rates were elevated in Q1 due to increased spot demand, but rates are expected to return to normal in Q2 [45][46] Question: Retaining spot business going forward - Management stated that spot volumes are opportunistic and not expected to be consistent [49] Question: Year-over-year EBITDA decline for Winchester - Management indicated that the decline is primarily due to lower commercial demand and higher costs, with a rough split of two-thirds volume and price, one-third cost [52][54] Question: Capacity overhang in epoxy - Management acknowledged significant capacity overhang in epoxy, particularly in Asia, and noted that the business will continue to struggle in 2025 [56][75] Question: Structural profitability of Winchester - Management expressed optimism about Winchester's future earnings, citing recent acquisitions and military project spending [70][72] Question: Increased cost-cutting target - Management clarified that the increased target includes both accelerated structural cost savings and productivity opportunities [79] Question: Capital spending reduction - Management confirmed that the reduction in capital spending for 2025 does not change the long-term average spending target [83] Question: Purchase price for Ammo Inc. - Management explained that the lower purchase price was due to effective negotiations and lower working capital at closing [88][89]